DuPont de Nemours (NYSE:DD – Free Report) had its price target upped by Royal Bank Of Canada from $160.00 to $173.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has an outperform rating on the basic materials company’s stock.
A number of other brokerages also recently weighed in on DD. Barclays increased their price target on DuPont de Nemours from $156.00 to $176.00 and gave the stock an “overweight” rating in a report on Wednesday. The Goldman Sachs Group dropped their price objective on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research note on Wednesday, September 30th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $172.00 to $145.00 in a research note on Friday, October 9th. UBS Group upped their target price on DuPont de Nemours from $172.00 to $182.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Citigroup raised their target price on DuPont de Nemours from $162.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday. Twelve research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, DuPont de Nemours has a consensus rating of “Moderate Buy” and a consensus target price of $165.88.
Get Our Latest Report on DuPont de Nemours
DuPont de Nemours Trading Down 4.0%
DD opened at $144.77 on Thursday. DuPont de Nemours has a twelve month low of $111.15 and a twelve month high of $157.98. The company has a quick ratio of 1.82, a current ratio of 2.36 and a debt-to-equity ratio of 0.23. The company has a fifty day moving average of $133.07 and a 200-day moving average of $138.70. The stock has a market cap of $19.55 billion, a PE ratio of 64.92, a price-to-earnings-growth ratio of 1.35 and a beta of 1.06.
DuPont de Nemours (NYSE:DD – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.22. The business had revenue of $1.87 billion during the quarter, compared to the consensus estimate of $1.84 billion. DuPont de Nemours had a net margin of 4.26% and a return on equity of 6.85%. DuPont de Nemours’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.09 earnings per share. On average, sell-side analysts predict that DuPont de Nemours will post 7.49 EPS for the current year.
DuPont de Nemours Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Monday, November 30th. DuPont de Nemours’s payout ratio is 107.62%.
Hedge Funds Weigh In On DuPont de Nemours
Institutional investors have recently made changes to their positions in the stock. Parallel Advisors LLC increased its position in DuPont de Nemours by 1.4% in the 3rd quarter. Parallel Advisors LLC now owns 6,340 shares of the basic materials company’s stock valued at $823,000 after buying an additional 87 shares in the last quarter. Center for Financial Planning Inc. raised its stake in DuPont de Nemours by 19.7% during the 3rd quarter. Center for Financial Planning Inc. now owns 607 shares of the basic materials company’s stock worth $79,000 after buying an additional 100 shares during the period. Brandywine Oak Private Wealth LLC raised its stake in DuPont de Nemours by 0.9% during the 3rd quarter. Brandywine Oak Private Wealth LLC now owns 12,301 shares of the basic materials company’s stock worth $1,598,000 after buying an additional 111 shares during the period. Americana Partners LLC boosted its holdings in DuPont de Nemours by 0.4% in the third quarter. Americana Partners LLC now owns 24,855 shares of the basic materials company’s stock worth $3,228,000 after acquiring an additional 111 shares in the last quarter. Finally, Providence Wealth Advisors LLC boosted its holdings in DuPont de Nemours by 2.2% in the third quarter. Providence Wealth Advisors LLC now owns 5,243 shares of the basic materials company’s stock worth $682,000 after acquiring an additional 113 shares in the last quarter. Institutional investors and hedge funds own 73.96% of the company’s stock.
DuPont de Nemours News Summary
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Several firms raised their price targets while maintaining bullish ratings: RBC lifted its target to $173 and kept an Outperform rating; Wells Fargo raised its target to $170 with an Overweight rating; UBS raised its target to $182 with a Buy rating; and Citi and Barclays each set targets of $176 with Buy or Overweight ratings. RBC price target article Wells Fargo price target article
- Positive Sentiment: DuPont’s latest reported quarter beat earnings and revenue expectations, with EPS of $2.09 versus the $1.87 consensus and revenue of $1.87 billion versus $1.84 billion expected. A report also noted the shares gapped up following the results. Shares gap up following earnings article
- Neutral Sentiment: A headline highlighted a new peptide-purification product, but the provided information does not detail its expected commercial impact. Peptide purification product article
DuPont de Nemours Company Profile
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Further Reading
- Five stocks we like better than DuPont de Nemours
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
